FDA Inspection 1055502 — BioStem Life Sciences

BioStem Life Sciences — FEI 3013239405

The FDA completed an inspection of BioStem Life Sciences on Jun 13, 2018 in Pompano Beach, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 13, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Pompano Beach, FL (United States)

Citations

IDCFRDescription
1239821 CFR 1271.230(a)Validation & approval--established procedures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.